Iowa State Bank Trimmed Its Glaxo Smithkline Plc (GSK) Stake; Arrowgrass Capital Partners LP Has Lowered Kinder Morgan Del (KMI) Position

May 19, 2018 - By Hazel Jackson

Kinder Morgan, Inc. (NYSE:KMI) Logo

Arrowgrass Capital Partners Lp decreased Kinder Morgan Inc Del (KMI) stake by 10.45% reported in 2017Q4 SEC filing. Arrowgrass Capital Partners Lp sold 105,500 shares as Kinder Morgan Inc Del (KMI)’s stock declined 16.40%. The Arrowgrass Capital Partners Lp holds 904,280 shares with $16.34M value, down from 1.01M last quarter. Kinder Morgan Inc Del now has $35.45 billion valuation. The stock decreased 1.41% or $0.23 during the last trading session, reaching $16.07. About 12.33M shares traded. Kinder Morgan, Inc. (NYSE:KMI) has declined 28.25% since May 19, 2017 and is downtrending. It has underperformed by 39.80% the S&P500.

Iowa State Bank decreased Glaxo Smithkline Plc (GSK) stake by 20.01% reported in 2017Q4 SEC filing. Iowa State Bank sold 9,461 shares as Glaxo Smithkline Plc (GSK)’s stock rose 9.28%. The Iowa State Bank holds 37,824 shares with $1.34M value, down from 47,285 last quarter. Glaxo Smithkline Plc now has $97.66B valuation. The stock decreased 0.17% or $0.07 during the last trading session, reaching $40.03. About 3.13M shares traded or 7.11% up from the average. GlaxoSmithKline plc (NYSE:GSK) has declined 10.07% since May 19, 2017 and is downtrending. It has underperformed by 21.62% the S&P500.

Analysts await Kinder Morgan, Inc. (NYSE:KMI) to report earnings on July, 18. They expect $0.19 EPS, up 35.71% or $0.05 from last year’s $0.14 per share. KMI’s profit will be $419.16 million for 21.14 P/E if the $0.19 EPS becomes a reality. After $0.22 actual EPS reported by Kinder Morgan, Inc. for the previous quarter, Wall Street now forecasts -13.64% negative EPS growth.

Among 25 analysts covering Kinder Morgan (NYSE:KMI), 17 have Buy rating, 0 Sell and 8 Hold. Therefore 68% are positive. Kinder Morgan had 85 analyst reports since July 30, 2015 according to SRatingsIntel. The stock has “Overweight” rating by Barclays Capital on Tuesday, April 17. The stock of Kinder Morgan, Inc. (NYSE:KMI) has “Buy” rating given on Friday, August 14 by Tudor Pickering. The stock of Kinder Morgan, Inc. (NYSE:KMI) earned “Buy” rating by Stifel Nicolaus on Thursday, July 13. Stifel Nicolaus maintained Kinder Morgan, Inc. (NYSE:KMI) on Monday, April 30 with “Buy” rating. On Tuesday, June 27 the stock rating was maintained by RBC Capital Markets with “Sector Perform”. The rating was downgraded by Argus Research on Thursday, December 3 to “Hold”. BMO Capital Markets maintained it with “Buy” rating and $2600 target in Thursday, July 27 report. RBC Capital Markets maintained the shares of KMI in report on Sunday, August 27 with “Hold” rating. The rating was maintained by Morgan Stanley on Friday, February 9 with “Overweight”. On Monday, August 21 the stock rating was maintained by Jefferies with “Hold”.

More important recent Kinder Morgan, Inc. (NYSE:KMI) news were published by: Seekingalpha.com which released: “Kinder Morgan: Too Cheap To Ignore” on April 26, 2018, also Seekingalpha.com published article titled: “Kinder Morgan: Is The Worst Behind Us?”, Seekingalpha.com published: “Kinder Morgan: Holding Pattern” on April 22, 2018. More interesting news about Kinder Morgan, Inc. (NYSE:KMI) was released by: Seekingalpha.com and their article: “Oil companies face increasing investor pressure on climate change action” with publication date: May 18, 2018.

Arrowgrass Capital Partners Lp increased Tesla Inc (NASDAQ:TSLA) stake by 66,025 shares to 66,100 valued at $20.58 million in 2017Q4. It also upped Avista Healthcare Pub Acq Co stake by 293,000 shares and now owns 1.79M shares. Andeavor (Call) was raised too.

Investors sentiment decreased to 0.7 in Q4 2017. Its down 0.07, from 0.77 in 2017Q3. It fall, as 75 investors sold KMI shares while 372 reduced holdings. 83 funds opened positions while 231 raised stakes. 1.31 billion shares or 0.25% more from 1.31 billion shares in 2017Q3 were reported. Estabrook Management stated it has 3,847 shares. Levin Cap Strategies Limited Partnership owns 385,695 shares or 0.12% of their US portfolio. Counsel owns 10,976 shares. Ci Invs holds 0.49% or 1.40 million shares in its portfolio. Yorkville Ltd Liability Corp accumulated 192,081 shares. Corecommodity Mngmt Limited Com accumulated 6,268 shares. The Tennessee-based Capwealth Advisors Limited Liability Corporation has invested 0.07% in Kinder Morgan, Inc. (NYSE:KMI). Cipher Capital LP holds 0.54% of its portfolio in Kinder Morgan, Inc. (NYSE:KMI) for 372,575 shares. Btr Cap Management Inc holds 391,172 shares. Ftb Advisors Incorporated owns 176,633 shares for 0.31% of their portfolio. Blackhill invested in 1.56% or 479,676 shares. Godsey And Gibb Assoc has 0.06% invested in Kinder Morgan, Inc. (NYSE:KMI) for 18,398 shares. The Michigan-based Ls Investment Advsrs Ltd Limited Liability Company has invested 0.07% in Kinder Morgan, Inc. (NYSE:KMI). North American Corp holds 0.04% or 13,200 shares. 219,912 were reported by Creative Planning.

Analysts await GlaxoSmithKline plc (NYSE:GSK) to report earnings on July, 25. They expect $0.78 EPS, up 11.43% or $0.08 from last year’s $0.7 per share. GSK’s profit will be $1.90 billion for 12.83 P/E if the $0.78 EPS becomes a reality. After $0.68 actual EPS reported by GlaxoSmithKline plc for the previous quarter, Wall Street now forecasts 14.71% EPS growth.

Among 18 analysts covering GlaxoSmithKline (NYSE:GSK), 9 have Buy rating, 1 Sell and 8 Hold. Therefore 50% are positive. GlaxoSmithKline had 29 analyst reports since September 8, 2015 according to SRatingsIntel. The stock has “Hold” rating by Cantor Fitzgerald on Friday, February 26. The stock of GlaxoSmithKline plc (NYSE:GSK) earned “Buy” rating by UBS on Monday, November 27. The stock of GlaxoSmithKline plc (NYSE:GSK) earned “Underweight” rating by Morgan Stanley on Friday, September 8. The firm has “Buy” rating given on Thursday, July 14 by Jefferies. The stock of GlaxoSmithKline plc (NYSE:GSK) earned “Underperform” rating by BNP Paribas on Wednesday, September 14. Cowen & Co maintained the stock with “Hold” rating in Monday, December 11 report. The stock of GlaxoSmithKline plc (NYSE:GSK) has “Buy” rating given on Tuesday, January 16 by Barclays Capital. The stock of GlaxoSmithKline plc (NYSE:GSK) has “Buy” rating given on Friday, May 26 by Berenberg. The firm has “Neutral” rating by Credit Suisse given on Tuesday, October 20. The firm earned “Hold” rating on Thursday, October 26 by Bank of America.

More notable recent GlaxoSmithKline plc (NYSE:GSK) news were published by: Seekingalpha.com which released: “Xenon Pharma up 21% premarket on positive XEN1101 data” on May 15, 2018, also Seekingalpha.com with their article: “GlaxoSmithKline Q1 2018: Still Too Many Uncertainties” published on April 29, 2018, Seekingalpha.com published: “FDA OKs expanded use for Glaxo’s Trelegy Ellipta” on April 24, 2018. More interesting news about GlaxoSmithKline plc (NYSE:GSK) were released by: Seekingalpha.com and their article: “GlaxoSmithKline Plc (GSK) Q1 2018 Results – Earnings Call Transcript” published on April 25, 2018 as well as Nasdaq.com‘s news article titled: “Myxoid/Round Cell Liposarcoma Data with NY-ESO and MAGE-A10 Study Update to be Presented at American …” with publication date: May 16, 2018.

Kinder Morgan, Inc. (NYSE:KMI) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Hazel Jackson

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: